Dott.ssa
Raffaella Mistrulli
Cardiologa
·
Altro
sulle specializzazioni
Roma 2 indirizzi
Tempo medio di risposta:
Esperienze
Sono la Dr.ssa Raffaella Mistrulli, medico chirurgo specialista in cardiologia, con una particolare competenza nelle tecniche di imaging cardiovascolare non invasivo e nella diagnostica cardiologica di precisione.
Mi sono laureata in Medicina e Chirurgia presso l'Università Sapienza di Roma con 110 e lode e mi sono specializzata in Malattie dell'Apparato Cardiovascolare con 70/70 e lode presso l'Azienda Ospedaliera Sant'Andrea della Sapienza. Ho perfezionato la mia formazione con una clinical fellowship in Non Invasive Cardiovascular Imaging all'OLV Ziekenhuis Hospital di Aalst, in Belgio, e ho conseguito il Diploma in Ecocardiografia Transesofagea rilasciato dalla European Association of Cardiovascular Imaging (EACVI). Sono inoltre dottoranda in Digital Cardiovascular Medicine, Pathology and Cutting-Edge Therapeutics, sempre alla Sapienza.
Nel corso della mia attività ho orientato la pratica clinica e la ricerca verso l'ecocardiografia diagnostica, sia semplice sia avanzata, affiancandola a un'intensa attività scientifica documentata da pubblicazioni nazionali e internazionali e da collaborazioni con istituzioni come l'Università di Tucson, in Arizona.
Mi occupo in particolare di valvulopatie, cardiomiopatie ed ecocardiografia semplice e complessa, compreso l'ecocardiogramma da sforzo. Eseguo visite cardiologiche, elettrocardiogramma, ecocardiogramma, ecostress, prova da sforzo e check-up cardiologici completi, oltre a visite specifiche per tachicardia, palpitazioni, extrasistoli e cardiopalmo.
Unisco rigore scientifico e attenzione alla persona: il mio obiettivo è offrire una diagnostica cardiologica accurata e accompagnare ogni paziente con chiarezza nel percorso più adatto alle sue esigenze.
Aree di competenza principali:
- Cardiologia
- Ecografista
Principali patologie trattate
- Valvulopatie
- Cardiomiopatie
- Ipertensione arteriosa
- Aritmia
- Insufficienza cardiaca
- +26 a11y_sr_more_diseases
Presso questo indirizzo visito
Adulti (Solo in alcuni indirizzi)
Bambini a partire da 8 anni (Solo in alcuni indirizzi)
Tipologia di visite
In studio
Visualizza gli indirizzi (1)
Foto e video
Esperienze
Raffaella Mistrulli
cardiologo
Tirocini
- Clinical Research Fellow in Imaging Cardiovascolare non invasivo presso il Cardiovascular Center OLV, Aalst ( Belgio)
Formazione
- Dottorato di ricerca in Digital Cardiovascular Medicine, Pathology and Cutting-Edge Therapeutics conseguito presso l’Università Sapienza di Roma
- Specializzazione in Malattie dell’Apparato Cardiovascolare conseguita presso l’Università Sapienza – Azienda Ospedaliera Sant’Andrea di Roma con la votazione di 70/70 e lode
- Laurea magistrale in Medicina e Chirurgia conseguita presso l’Università Sapienza di Roma con la votazione di 110/110 e lode
Certificati
Patologie trattate
- Valvulopatie
- Cardiomiopatie
- Ipertensione arteriosa
- Aritmia
- Insufficienza cardiaca
- Insufficienza tricuspidale
- Dolore toracico
- Coronaropatia
- Ipercolesterolemia
- Cardiopalmo
- Aterosclerosi
- Ipertensione polmonare
- Ipertensione
- Edema
- Obesità
- Arteriosclerosi
- Sindrome di Brugada
- Scompenso cardiaco
- Trombosi
- Trombosi coronarica
- Angina
- Extrasistole
- Tachicardia parossistica (TPSV)
- Insufficienza coronarica
- Sindrome di Eisenmenger
- Endocardite
- Sindrome Metabolica
- Flutter atriale
- Tachicardia ventricolare
- Fibrillazione ventricolare
- Soffio cardiaco
Competenze linguistiche
- Inglese
- Italiano
Pubblicazioni
- Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals (Frontiers in cardiovascular medicine, 2023)
- Takotsubo syndrome: More frequent in women, more dangerous in men (European Heart Journal Supplements, 2023)
- Contemporary management of cardiogenic shock complicating acute myocardial infarction (Journal of Clinical Medicine, 2023)
- Atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac amyloidosis: from clinical management to catheter ablation indication (Journal of Clinical Medicine, 2024)
- Acute coronary syndrome and renal impairment: a systematic review (Reviews in Cardiovascular Medicine, 2022)
- Cardiomyopathy and sudden cardiac death: bridging clinical practice with cutting-edge research (Biomedicines, 2024)
- A contemporary update on cancer and takotsubo syndrome (Frontiers in Cardiovascular Medicine, 2024)
- Post-COVID postural orthostatic tachycardia syndrome and inappropriate sinus tachycardia in the pediatric population (Current Clinical Microbiology Reports, 2024)
- SARS-CoV-2 related myocarditis: what we know so far (Journal of Clinical Medicine, 2023)
- Antithrombotic strategies in patients with atrial fibrillation and acute coronary syndromes undergoing percutaneous coronary intervention (Journal of Clinical Medicine, 2022)
- Lipid accumulation product and cardiometabolic index as effective tools for the identification of athletes at risk for metabolic syndrome (Life, 2024)
- Cardio-oncology rehabilitation: are we ready? (European Heart Journal Supplements, 2024)
- The impact of disopyramide on exercise capacity among patients with obstructive hypertrophic cardiomyopathy: beyond left ventricular outflow tract gradient (European Journal of Preventive Cardiology, 2025)
- Cardiac toxicity of chemotherapy for breast cancer: do angiotensin-converting enzyme inhibitors and beta blockers protect? (European Heart Journal Supplements, 2023)
- Natural history of patients with histologically proven acute eosinophilic myocarditis (Circulation, 2026)
- Predictors of permanent pacemaker implantation after TAVI with Navitor transcatheter heart valve (Cardiovascular Revascularization Medicine, 2025)
- Association of cardiac damage and computed tomography–derived extracellular volume in patients undergoing transcatheter aortic valve implantation (Canadian Journal of Cardiology, 2025)
- Artificial intelligence for perioperative risk assessment in minimally invasive cardiac surgery: current applications and future perspectives (Mini-invasive Surgery, 2025)
- Artificial intelligence–assisted electrocardiography: a new and easily accessible approach for diagnosing cancer therapy–related cardiac dysfunction (European Journal of Preventive Cardiology, 2024)
- Scientific statement ANMCO sulla semplificazione del regime terapeutico farmacologico in prevenzione secondaria (Giornale Italiano di Cardiologia, 2024)
- Cardiopulmonary exercise test and stress echocardiography in Fabry cardiomyopathy: insights into functional impairment and risk stratification (European Heart Journal–Quality of Care and Clinical Outcomes, 2026)
- Myocardial work parameters in left bundle branch area pacing versus other pacing techniques: a systematic review and aggregate comparative analysis (IJC Heart & Vasculature, 2025)
- Pulmonary Valve Endocarditis: Always Look on the (B) right Side! (CASE, 2024)
- Cardioncogeriatria: position paper ANMCO sulla gestione cardioncologica del paziente anziano (Giornale Italiano di Cardiologia, 2022)
- Structural changes in the left atrial appendage before and after pulsed field ablation for atrial fibrillation (Heart Rhythm, 2026)
- A Personalized Approach for Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries (Reviews in Cardiovascular Medicine, 2024)
- Current Data and Future Perspectives on Patients with Atrial Fibrillation and Cancer (Cancers, 2023)
- Cardio-oncogeriatrics: ANMCO position paper on cardio-oncology management of elderly patients (Giornale Italiano di Cardiologia (2006), 2022)
- Features and follow-up of patients affected by noninflammatory myocarditis after coronavirus disease 2019 vaccination (Journal of Cardiovascular Medicine, 2022)
- Severe LVOT obstruction in HCM: effects on exercise capacity and outcomes from cardiopulmonary exercise testing combined with stress echocardiography (European Heart Journal–Quality of Care and Clinical Outcomes, 2026)
- Atrial fibrillation recurrence in patients with transthyretin cardiac amyloidosis undergoing pulmonary veins isolation (Journal of Interventional Cardiac Electrophysiology, 2025)
- Integrated severity staging of paravalvular regurgitation after transcatheter aortic valve implantation using echocardiographic and hemodynamic assessment (The American Journal of Cardiology, 2025)
- Ultrasound-guided puncture of femoral veins versus standard palpation approach in patients undergoing pulmonary vein isolation (Journal of Interventional Cardiac Electrophysiology, 2025)
- Novel Right Ventricular Function Parameters can Identify Short-Term Nonresponders to Transcatheter Edge-to-Edge Repair for Mitral Regurgitation (The American Journal of Cardiology, 2025)
- HYPERTROPHIC CARDIOMYOPATHY IN FOCUS: CLINICAL CHARACTERISTICS, GENETIC INFLUENCES, AND PROGNOSTIC IMPLICATIONS (European Heart Journal Supplements, 2025)
- ANMCO Scientific statement on combination therapies and polypill in secondary prevention (Giornale Italiano di Cardiologia (2006), 2024)
- The role of genetic testing in suspected fulminant myocarditis: A case report (Molecular Genetics and Metabolism Reports, 2023)
- Acute myocarditis following covid-19 vaccination: a peculiar case series (Journal of Hypertension, 2022)
- Imaging and biomarker-based risk stratification in TAVI: the role of epicardial fat, visceral fat, and adiponectin (European Heart Journal Open, 2026)
- Integrating Cardiopulmonary Exercise Testing, Stress Echocardiography and Near-Infrared Spectroscopy for Multimodal Assessment of Exercise Intolerance: A Narrative Review (Healthcare, 2026)
- Insights Into the Natural History of Recurrent Myocarditis, A Multicenter International Study (Re-Myo Study) (Journal of the American Heart Association, 2026)
- NOVEL RIGHT VENTRICULAR FUNCTION PARAMETERS CAN IDENTIFY SHORT–TERM NON–RESPONDERS TO TRANSCATHETER EDGE–TO–EDGE REPAIR FOR MITRAL REGURGITATION (European Heart Journal Supplements, 2026)
- UNMASKING THE IMPACT OF SEVERE LVOT OBSTRUCTION IN HYPERTROPHIC CARDIOMYOPATHY BY COMBINED STRESS ECHOCARDIOGRAPHY AND CARDIOPULMONARY EXERCISE TESTING (European Heart Journal Supplements, 2026)
- RIGHT VENTRICULAR METASTASIS OF RENAL CELL CARCINOMA AND LATE–ONSET ICI–INDUCED MYOCARDITIS: A COMPLEX CARDIO–ONCOLOGY SCENARIO (European Heart Journal Supplements, 2026)
- IMPLEMENTING THE CARDIO–KIDNEY–METABOLIC (CKM) FRAMEWORK TO BRIDGE THE THERAPEUTIC GAP IN HEART FAILURE: RESULTS FROM A REAL–WORLD QUALITY IMPROVEMENT PROJECT (European Heart Journal Supplements, 2026)
- VARIATION IN COMBINED CARDIOPULMONARY EXERCISE TEST AND STRESS ECHOCARDIOGRAPHY FINDINGS IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHYC CARDIOMYOPATHY TREATED WITH MAVACAMTEN (European Heart Journal Supplements, 2026)
- HEART FAILURE AS A CLIMATE–SENSITIVE SYNDROME: ENVIRONMENTAL STRESSORS, VULNERABLE PHENOTYPES, AND CLINICAL IMPLICATIONS (European Heart Journal Supplements, 2026)
- Machine Learning–Based Risk Stratification in Hypertrophic Cardiomyopathy: The Added Prognostic Value of Combined Cardiopulmonary Exercise Testing and Stress Echocardiography (Circulation, 2025)
- Impact of left bundle branch area pacing on myocardial work: a systematic review and aggregate comparative analysis (European Heart Journal, 2025)
- Epidemiology of bloodstream infections and infective endocarditis: new insights on typically associated species definitions and use of echocardiography screening (European Heart Journal, 2025)
- Improving risk stratification in TAVI: the role of epicardial fat, visceral fat and adiponectin (European Heart Journal, 2025)
- Non-invasive left ventricle strain-volume-pressure loops in asymptomatic significant aortic regurgitation and their role in predicting the need for aortic valve surgery (European Heart Journal, 2025)
- Integrating Cardiopulmonary Exercise Testing and Stress Echocardiography to Predict Clinical Outcomes in Hypertrophic Cardiomyopathy (Journal of Clinical Medicine, 2025)
- Fit but not immune from the risk: the hidden burden of dyslipidemia in elite athletes (European Journal of Preventive Cardiology, 2025)
- The diagnostic accuracy of contemporary ECG interpretation criteria in risk stratification of master athletes (Frontiers in Cardiovascular Medicine, 2025)
- Unveiling Functional Impairment in Fabry Disease: The Role of Peripheral vs. Cardiac Mechanisms (Biomedicines, 2025)
- Enhancing procedural efficiency in pulsed field ablation: the role of integrated 3D rotational angiography and fluoroscopy fusion (Hellenic Journal of Cardiology, 2025)
- ST-elevation myocardial infarction late-presenting patients: time for a new paradigm? (Monaldi Archives for Chest Disease, 2025)
- PREDICTING ADVERSE OUTCOMES IN HYPERTROPHIC CARDIOMYOPATHY: THE PIVOTAL ROLE OF CARDIOPULMONARY EXERCISE TESTING (European Heart Journal Supplements, 2025)
- Transmitral Doppler flow reflecting elevated pulsatility index in a HeartMate III assist device (European Heart Journal-Cardiovascular Imaging, 2025)
- Association of Extra-valvular Cardiac Damage and CCT-derived Extracellular Volume in Patients With Severe Aortic Stenosis Undergoing TAVI (Journal of Cardiovascular Computed Tomography, 2025)
- Left ventricular pressure-strain-volume-loop and myocardial work patterns in asymptomatic severe aortic regurgitation with early disease decompensation (European Heart Journal-Cardiovascular Imaging, 2025)
- Beyond the walk: the prognostic value of dyspnoea in heart failure (European Journal of Preventive Cardiology, 2024)
- Could we use cardiopulmonary exercise test to distinguish hypertrophic cardiomyopathy from Fabry disease? New insights from Italy (European Journal of Heart Failure, 2024)
- ATRIAL FIBRILLATION AND CARDIOTOXICITY: IS TRANSCATHETER ABLATION AN EFFECTIVE STRATEGY? (European Heart Journal Supplements, 2024)
- Position paper ANMCO in collaborazione con ITACARE-P: Riabilitazione cardio-oncologica. Are we ready? (Giornale Italiano di Cardiologia, 2024)
- Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on the simplification of the drug regimen for secondary cardiovascular prevention (European Heart Journal Supplements, 2024)
- AN INCIDENTAL DIAGNOSIS OF ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA (European Heart Journal Supplements, 2024)
- ANMCO Position paper in collaboration with ITACARE-P: Cardio-oncology rehabilitation. Are we ready? (Giornale Italiano di Cardiologia (2006), 2024)
- THE BROAD PHENOTYPIC SPECTRUM OF ARRHYTHMOGENIC CARDIOMYOPATHY (European Heart Journal Supplements, 2024)
- Corrigendum: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals (Frontiers in Cardiovascular Medicine, 2023)
- C31 NEXT GENERATION MYOCARDITIS (European Heart Journal Supplements, 2023)
- P278 A RARE CASE OF RECURRENT SARS–COV–2 MRNA VACCINE–INDUCED PERICARDITIS (European Heart Journal Supplements, 2023)
- P249 INTRAMYOCARDIAL HAEMATOMA AS A COMPLICATION OF ACUTE MYOCARDIAL INFARCTION (European Heart Journal Supplements, 2023)
- P421 INTRA–CARDIAC AND ALL LAYERS CARDIAC INVOLVEMENT BY SQUAMOUS NON–SMALL CELL LUNG CANCER (European Heart Journal Supplements, 2023)
- P140 EFFICACY AND SAFETY OF CHEMOTHERAPY CONTAINING NON–PEGYLATED LIPOSOMAL DOXORUBICIN IN PATIENTS AT HIGH CARDIOVASCULAR RISK: A SINGLE–CENTER EXPERIENCE (European Heart Journal Supplements, 2022)
- C50 CARDIO–ONCO–HAEMATOLOGY IN CLINICAL PRACTICE. A 'CHANGELING' CASE: MORE THAN PARADOXICAL BUBBLES (European Heart Journal Supplements, 2022)
Premi e riconoscimenti
- Reviewer for High Blood Pressure & Cardiovascular Prevention, official journal of the Italian Society of Hypertension (SIIA), 2022.
- Co-Investigator studio “MYTHS- Myocarditis THerapy with Steroids” sponsorizzato da ASST Grande Ospedale Metropolitano Niguarda (hereafter named Niguarda Hospital), Milano, Italy. 2022-2023
- Investigator studio “XATOC – Xarelto + Acetylsalicylic Acid: Treatment patterns and Outcomes across the disease Continuum in patients with CAD and/or PAD”, sponsorizzato da Bayer. 2022
- Investigator studio “RITMUS-AF- Rivaroxaban treatment discontinuation rates in routine clinical practice in Italy in patients with non-valvular atrial fibrillation”, sponsorizzato da Bayer. 2022
Prestazioni e prezzi
-
Visita cardiologica
Da 100 € -
-
Ecostress
250 € -
-
Visita cardiologica di controllo
80 € -
-
Visita cardiologica + elettrocardiogramma (ECG)
0 € - 120 € -
-
Elettrocardiogramma
0 € - 50 € -
-
-
-
-
-
-
-
-
-
-
-
-
-
Indirizzi (2)
Sanismart Medical Center
Viale Carlo Felice 93, Roma 00185
Disponibilità
Modalità di pagamento (visite private)
- Carta di credito
- Bonifico istantaneo
- Carta di debito
- Carta prepagata
Telefono
06 9603...
Telefono
Sanismart Medical Center
Risparmia tempo! Prenota online:
Prenota senza telefonare e senza costi aggiuntivi, selezionando una data disponibile. Dopo la prenotazione riceverai email di conferma e promemoria tramite SMS.
Puoi anche inviare un messaggio
Tempo medio di risposta:
320 175...
Telefono
Sanismart Medical Center
Risparmia tempo! Prenota online:
Prenota senza telefonare e senza costi aggiuntivi, selezionando una data disponibile. Dopo la prenotazione riceverai email di conferma e promemoria tramite SMS.
Puoi anche inviare un messaggio
Tempo medio di risposta:
Polisan Poliambulatorio
Piazza della Costituzione , Potenza 85100
Disponibilità
Questo dottore non offre prenotazioni online a questo indirizzo
Modalità di pagamento (visite private)
- Carta prepagata
- Contanti
- Carta di debito
- Carta di credito
Recensioni
1 recensione
Tutte le recensioni contano e non possono essere rimosse o modificate dai dottori a proprio piacimento.
Scopri come funziona il processo di moderazione delle recensioni.
Per saperne di più sulle opinioni
-
G
Giovanni
La dottoressa Mistrulli è molto preparata, professionale e disponibile. Mi ha messo subito a mio agio, spiegando tutto con chiarezza e attenzione. Visita accurata e grande umanità. La consiglio vivamente.
• Sanismart Medical Center • visita cardiologica •
Cardiologi nelle vicinanze
Principali patologie trattate
Informazioni sul prezzo
Sanismart Medical Center
I prezzi di alcune prestazioni possono variare a seconda del singolo caso. Dopo aver effettuato una prenotazione, puoi chiedermi il prezzo di una specifica prestazione inviandomi un messaggio privato. Prenota ora la data più adatta alle tue esigenze.
Hai dubbi o domande?
Tempo medio di risposta:
La prenotazione e la cancellazione della visita sono servizi gratuiti